Dalcetrapib

Overview

Dalcetrapib (JTT-705) is an orally active cholesteryl ester transfer protein ( CETP ) inhibitor with IC 50 s of 204.6 nM and 6 μM against recombinant human (rh) CETP and human plasma CETP , respectively.

Application

Products | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Cancer | Products > Disease Areas > Cardiovascular Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Cardiovascular Disease | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Signaling Pathways > CETP

Product Information

• Catalog No.: HY-14950
• CAS No.: 211513-37-0
• Molecular Formula: C23H35NO2S
• Molecular Weight: 389.59
• Purity: 99.19%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
• Solubility: ≥ 2.5 mg/mL (6.42 mM); Clear solution
• Availability: In-stock

Source

Original product source